跳至主要内容
临床试验/NCT00250211
NCT00250211已完成1 期

Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

AHS Cancer Control Alberta2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2005年3月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
26
试验地点
2
主要终点
determine tumor response and pattern of failure using functional MRI imaging

研究概览

简要总结

The purpose of this study is to learn whether 3 tesla (3T) MRI functional imaging will map a tumor more accurately allowing a more targeted delivery of radiation. The investigators hope to learn whether tomotherapy will be able to deliver higher radiation doses safely to the tumor while sparing the surrounding normal tissue.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed glioblastoma multiforme
  • Ages 18-65
  • Karnofsky Performance Scale (KPS) equal to or less than 70
  • Minimal neurological deficit
  • Eligible for concurrent temozolomide chemotherapy

排除标准

  • Prior radiation therapy to hand or neck area, chemotherapy, or radiosensitizer

结局指标

主要结局

determine tumor response and pattern of failure using functional MRI imaging

时间窗: Study completion

time to disease progression

时间窗: Study completion

次要结局

  • survival
  • distinguish residual tumor from treatment-related necrosis(study completion)
  • acute late toxicity of tomotherapy and hypofractionation

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验